AU2016901339A0 - Compositions and methods of use - Google Patents
Compositions and methods of useInfo
- Publication number
- AU2016901339A0 AU2016901339A0 AU2016901339A AU2016901339A AU2016901339A0 AU 2016901339 A0 AU2016901339 A0 AU 2016901339A0 AU 2016901339 A AU2016901339 A AU 2016901339A AU 2016901339 A AU2016901339 A AU 2016901339A AU 2016901339 A0 AU2016901339 A0 AU 2016901339A0
- Authority
- AU
- Australia
- Prior art keywords
- compositions
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title 1
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2017250002A AU2017250002B2 (en) | 2016-04-11 | 2017-04-10 | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier |
US16/092,291 US10874629B2 (en) | 2016-04-11 | 2017-04-10 | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier |
KR1020187031409A KR102434254B1 (en) | 2016-04-11 | 2017-04-10 | An ophthalmic composition comprising levodopa, an antioxidant and an aqueous carrier |
PCT/AU2017/050310 WO2017177262A1 (en) | 2016-04-11 | 2017-04-10 | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier |
EP17781629.5A EP3442516A4 (en) | 2016-04-11 | 2017-04-10 | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier |
MYPI2018703517A MY190011A (en) | 2016-04-11 | 2017-04-10 | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier |
JP2018553929A JP7095873B2 (en) | 2016-04-11 | 2017-04-10 | Ophthalmic composition comprising levodopa, antioxidant and aqueous carrier |
CA3019178A CA3019178A1 (en) | 2016-04-11 | 2017-04-10 | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier |
TW106111880A TWI793072B (en) | 2016-04-11 | 2017-04-10 | Compositions and methods of use |
KR1020227028216A KR102578476B1 (en) | 2016-04-11 | 2017-04-10 | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier |
SG11201808713YA SG11201808713YA (en) | 2016-04-11 | 2017-04-10 | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier |
CN201780034347.XA CN109310658A (en) | 2016-04-11 | 2017-04-10 | Ophthalmic composition comprising levodopa, antioxidant and aqueous carrier |
IL262294A IL262294A (en) | 2016-04-11 | 2018-10-11 | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier |
US17/103,709 US11890266B2 (en) | 2016-04-11 | 2020-11-24 | Ophthalmic compositions including levodopa, an antioxidant and an aqueous carrier |
JP2022094850A JP2022116357A (en) | 2016-04-11 | 2022-06-13 | Ophthalmic compositions comprising levodopa, antioxidant and aqueous carrier |
AU2023201671A AU2023201671A1 (en) | 2016-04-11 | 2023-03-17 | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2016901339A0 true AU2016901339A0 (en) | 2016-04-21 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3704239A4 (en) | Casz compositions and methods of use | |
EP3429635A4 (en) | Anti-crispr compounds and methods of use | |
EP3402549A4 (en) | Microneedle compositions and methods of using same | |
EP3504213A4 (en) | Amino-pyrrolopyrimidinone compounds and methods of use thereof | |
EP3576782A4 (en) | Construct-peptide compositions and methods of use thereof | |
EP3704254A4 (en) | Cas12c compositions and methods of use | |
EP3352774A4 (en) | Flavonoid compositions and methods of use | |
EP3595653A4 (en) | Compositions of plinabulin and use thereof | |
EP3245291A4 (en) | Novel micro-dystrophins and related methods of use | |
EP3435956A4 (en) | Photo-stabilized compositions and methods of use | |
EP3436061A4 (en) | Saccharide-polypeptide conjugate compositions and methods of use thereof | |
EP3548033A4 (en) | Compounds and their methods of use | |
EP3337823A4 (en) | Carrier-binding agent compositions and methods of making and using the same | |
EP3268018A4 (en) | Bacterial compositions and methods of use thereof | |
EP3092001A4 (en) | Immunomodulatory compositions and methods of use thereof | |
EP3386927A4 (en) | Polymer compositions and methods of use | |
EP3116511A4 (en) | Compositions of selenoorganic compounds and methods of use thereof | |
EP3534710A4 (en) | Coating compositions and methods of use thereof | |
EP3341017A4 (en) | Immunomodulatory compositions and methods of use thereof | |
EP3166892A4 (en) | Scale-inhibition compositions and methods of making and using the same | |
EP3600372A4 (en) | Synthekine compositions and methods of use | |
EP3190886A4 (en) | Compositions and methods of use thereof | |
EP3110891A4 (en) | Low-voc compositions and methods of making and using the same | |
EP3541847A4 (en) | Glycan-interacting compounds and methods of use | |
EP3402443A4 (en) | Devices and compositions and methods of use thereof |